catapres- clonidine patch, extended release
rebel distributors corp - clonidine (unii: mn3l5rmn02) (clonidine - unii:mn3l5rmn02) - clonidine 0.1 mg in 24 h - catapres-tts® (clonidine) transdermal therapeutic system is indicated in the treatment of hypertension. it may be employed alone or concomitantly with other antihypertensive agents. catapres-tts transdermal therapeutic system should not be used in patients with known hypersensitivity to clonidine or to any other component of the therapeutic system.
catapres-tts- clonidine patch
boehringer ingelheim pharmaceuticals inc. - clonidine (unii: mn3l5rmn02) (clonidine - unii:mn3l5rmn02) - clonidine 0.1 mg in 1 d - catapres‑tts transdermal therapeutic system is indicated in the treatment of hypertension. it may be employed alone or concomitantly with other antihypertensive agents. catapres‑tts transdermal therapeutic system should not be used in patients with known hypersensitivity to clonidine or to any other component of the therapeutic system.
catapres tab 0.1mg tablet
boehringer ingelheim (canada) ltd ltee - clonidine hydrochloride - tablet - 0.1mg - clonidine hydrochloride 0.1mg - central alpha-agonists
catapres tab 0.2mg tablet
boehringer ingelheim (canada) ltd ltee - clonidine hydrochloride - tablet - 0.2mg - clonidine hydrochloride 0.2mg - central alpha-agonists
catapres tab. 0.150 mg
boehringer ingelheim sceintific office - tablet - 0.15 mg
catapres- clonidine hydrochloride tablet
boehringer ingelheim pharmaceuticals inc. - clonidine hydrochloride (unii: w76i6xxf06) (clonidine - unii:mn3l5rmn02) - clonidine hydrochloride 0.100 mg - catapres tablets are indicated in the treatment of hypertension. catapres tablets may be employed alone or concomitantly with other antihypertensive agents. catapres® (clonidine hydrochloride, usp) tablets should not be used in patients with known hypersensitivity to clonidine (see precautions ).
catapres-tts-1- clonidine transdermal system patch catapres-tts-2- clonidine transdermal system patch catapres-tts-3- clonidin
technomed inc. - clonidine (unii: mn3l5rmn02) (clonidine - unii:mn3l5rmn02) - catapres‑tts® is indicated in the treatment of hypertension. it may be employed alone or concomitantly with other antihypertensive agents. catapres‑tts® should not be used in patients with known hypersensitivity to clonidine or to any other component of the transdermal system.
dixarit 25microgram tablets
boehringer ingelheim ltd - clonidine hydrochloride - oral tablet - 25microgram
catapres-tts
carsl consulting - clonidine 2.5mg - transdermal patch - 2.5 mg - active: clonidine 2.5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.
catapres-tts
carsl consulting - clonidine 5mg - transdermal patch - 5 mg - active: clonidine 5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.